Pathology

Papers
(The H4-Index of Pathology is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation152
SARS-CoV-2 in children: spectrum of disease, transmission and immunopathological underpinnings74
The 2019 World Health Organization Classification of appendiceal, colorectal and anal canal tumours: an update and critical assessment64
Laboratory biosafety measures involving SARS-CoV-2 and the classification as a Risk Group 3 biological agent51
Clear cell papillary renal cell carcinoma: an update after 15 years38
Chromophobe renal cell carcinoma: current and controversial issues36
Circulating plasma miR-155 is a potential biomarker for the detection of SARS-CoV-2 infection34
Head-to-head evaluation on diagnostic accuracies of six SARS-CoV-2 serological assays33
Clinical and molecular implications of NAB2-STAT6 fusion variants in solitary fibrous tumour33
Sample pooling is a viable strategy for SARS-CoV-2 detection in low-prevalence settings31
The concept of mesothelioma in situ, with consideration of its potential impact on cytology diagnosis27
Evaluation of the BioFire Blood Culture Identification 2 panel and impact on patient management and antimicrobial stewardship26
The impact of viral transport media on PCR assay results for the detection of nucleic acid from SARS-CoV-226
Staging of renal cell carcinoma: current progress and potential advances26
PD-1/PD-L1, Treg-related proteins, and tumour-infiltrating lymphocytes are associated with the development of oral squamous cell carcinoma25
Evaluating errors in the laboratory identification of von Willebrand disease using contemporary von Willebrand factor assays25
Angiomyolipoma of the kidney: from simple hamartoma to complex tumour24
A multicentre assessment of contemporary laboratory assays for heparin induced thrombocytopenia23
Emergence of Japanese encephalitis in Australia: a diagnostic perspective23
Urothelial carcinoma: variant histology, molecular subtyping, and immunophenotyping significant for treatment outcomes21
INSM1 is a novel prognostic neuroendocrine marker for luminal B breast cancer20
0.15635681152344